Dear Friends and Colleagues,
We’re hiring!
By the end of the year the Fralin Biomedical Research Institute at VTC expects to make offers to up to seven new primary faculty researchers. Of those, three would join our team in Washington, D.C., and the other four would set up labs in Roanoke.
Our faculty and staff have been spreading the word at conferences and sharing the news on job-search sites. Because of their efforts, and because word is getting out about our innovative and supportive culture, it’s been a welcome challenge to select finalists from such a talented pool of top-tier applicants.
Earlier this month I traveled to Washington, D.C., where we hosted a candidate for one of our new positions in cancer research at the Children’s National Research & Innovation Campus. We will also host several additional candidates for that position and another pediatric cancer position.
We’re also recruiting for a health behaviors researcher focused on cancer prevention; a cancer researcher with a focus on biomaterials; and a researcher focused on therapeutic use of focused ultrasound for treating brain cancer.
Meanwhile, we are also recruiting new faculty for the Roanoke campus in exercise medicine research and developmental neuroscience to grow our strong programs in those areas.
The Red Gates Foundation's extraordinary $50 million gift to expand our health sciences research, with a particular focus on cancer, is still resonating throughout Virginia Tech and the region.
When all searches are successfully completed, the Fralin Biomedical Research Institute will have 45 primary faculty-led research programs. We won’t be able to rest long, because with those new positions will come more recruiting for the research teams and other staff to support their science.
These are exciting times, and I look forward to sharing the results with you in the coming months.
Best wishes to you and your families for a happy and healthful Thanksgiving holiday!
Yours truly in the spirit of Ut Prosim,
Michael J. Friedlander, Ph.D.
Executive Director, Fralin Biomedical Research Institute at VTC
Vice President for Health Sciences and Technology, Virginia Tech
Senior Dean for Research, Virginia Tech Carilion School of Medicine
Professor, Biological Sciences, Biomedical Engineering and Psychiatry and Behavioral Medicine
|
|
Researchers use pioneering new method to unlock brain's noradrenaline system
The research institute leads an international effort to record real-time chemical activity in the conscious human brain using clinical electrodes. Read Story
|
|
|
New cancer drug shows promise in targeting genetic weakness in tumors, Virginia Tech expert says
In the journal Cancer Discovery, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute, talks about the potential of the new drug. Read Story
|
|
|
Interdisciplinary team receives $5 million grant to explore COVID-19 at the human-animal interface
Carla Finkielstein is part of a team taking an interdisciplinary approach to exploring the potential risks to public health posed by the virus in wildlife. Read Story
|
|
|
Pearl Chiu named Patricia Caldwell Faculty Fellow
Chiu aims to understand how brain function and decision-making are affected in illnesses such as depression and addiction. Read Story
|
|
|
Digging for Data: Researcher seeks new therapeutic interventions for progressive, chronic lung disease
New Postdoctoral Excellence Award from the Fralin Biomedical Research Institute will fuel Samar Antar's research. Read Story
|
|
|
Gaskins fellowship will support doctoral student's goal of becoming a physician-scientist
Renesa Tarannum, who earned a medical degree in Bangladesh, is working on her doctoral research while making progress toward becoming a licensed U.S. physician. Read Story
|
|
|
RESCHEDULED: Advances in Frontotemporal Dementia: From Diagnosis to Treatment, originally planned for December, will now be March 7, 2024.
Speaker: Bruce Miller, M.D., Director, Global Brain Health Institute, UC San Francisco.
|
|
Cancer researcher Kathleen Mulvaney's invited review of a new cancer drug drew broad attention in the science press, while news of a study of tobacco tax policy by Research Assistant Professor Roberta Freitas Lemos was also picked up by news outlets. And interest in Alexandra DiFeliceantonio's take on the addictive nature of ultra-processed foods remained high.
- Kathleen Mulvaney, a cancer researcher in Fralin Biomedical Research Institute's labs on the Children's National Research & Innovation Campus in Washington, D.C., was invited by the journal Cancer Discovery to write a review of the potential of a new cancer drug. News of her review was picked up by numerous science press outlets, including Bioengineer, nxtlifescience, and France's MA Clinique.
- Taxes are widely used to reduce tobacco use, but can also exacerbate socioeconomic disparities. Roberta Freitas Lemos of the Bickel Lab earned a grant from the National Cancer Institute to study that relationship, news that was shared by Tobacco Reporter.
- Alexandra DiFeliceantonio has become a regular in news media conversations about the addictive nature of ultra-processed foods, which make up a significant portion of the American diet. Most recently she was quoted in an article for Australia's What's New in Food Technology & Manufacturing and was a guest on KMOX radio in St. Louis.
View the full list of media mentions.
|
|
Here's how you can support the Fralin Biomedical Research Institute in advancing human health through science:
|
|
|
|
|
|
